
Last update at 2026-06-22T16:28:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Corbion General Shareholders Meeting approves Board (re)appointments and dividend
Wed 14 May 25, 03:07 PMBe Sure To Check Out Corbion N.V. (AMS:CRBN) Before It Goes Ex-Dividend
Sun 11 May 25, 06:20 AM3 Top Undervalued European Small Caps With Recent Insider Activity
Tue 06 May 25, 05:39 AMCorbion's (AMS:CRBN) Shareholders Will Receive A Bigger Dividend Than Last Year
Fri 02 May 25, 04:27 AMCorbion announces strong first quarter 2025 results, well on track to deliver full-year outlook
Wed 23 Apr 25, 05:00 AMEuropean Dividend Stocks To Consider In April 2025
Tue 15 Apr 25, 10:31 AMCorbion's (AMS:CRBN) Upcoming Dividend Will Be Larger Than Last Year's
Sat 05 Apr 25, 06:02 AM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 91.15M | 62.50M | 85.30M | 116.40M | 86.50M |
| Minority interest | 0.00000M | 0.00000M | - | - | - |
| Net income | 71.85M | 192.20M | 72.90M | 90.00M | 78.30M |
| Selling general administrative | 171.00M | 113.30M | 103.20M | 92.40M | 85.50M |
| Selling and marketing expenses | - | 74.30M | 74.10M | 81.10M | 67.50M |
| Gross profit | 317.26M | 312.10M | 352.70M | 324.30M | 265.80M |
| Reconciled depreciation | 85.80M | 86.80M | 84.60M | 76.40M | 64.10M |
| Ebit | 111.90M | 85.20M | 115.80M | 110.80M | 65.00M |
| Ebitda | 194.32M | 172.00M | 198.00M | 200.30M | 129.10M |
| Depreciation and amortization | 82.41M | 86.80M | 82.20M | 89.50M | 64.10M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 111.90M | 77.30M | 77.30M | 110.80M | 65.00M |
| Other operating expenses | 1105.48M | 1210.80M | 1186.80M | 1354.30M | 1023.80M |
| Interest expense | 21.23M | 22.70M | 29.70M | 17.00M | 13.70M |
| Tax provision | 20.10M | 16.60M | 12.40M | 26.40M | 8.20M |
| Interest income | 4.60M | 11.50M | 6.40M | 3.40M | 4.40M |
| Net interest income | -17.50000M | -11.20000M | -24.40000M | -14.40000M | -8.90000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 19.31M | 16.60M | 12.40M | 26.40M | 8.20M |
| Total revenue | 1217.38M | 1288.10M | 1443.80M | 1457.90M | 1070.80M |
| Total operating expenses | 205.36M | 234.80M | 228.10M | 220.70M | 218.80M |
| Cost of revenue | 900.12M | 976.00M | 1091.10M | 1133.60M | 805.00M |
| Total other income expense net | -20.74751M | -14.80000M | -31.90000M | 5.60M | 21.50M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 74.80M | 45.90M | 72.90M | 90.00M | 78.30M |
| Net income applicable to common shares | - | - | - | 90.00M | 78.30M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1416.30M | 1546.30M | 1699.70M | 1705.40M | 1341.10M |
| Intangible assets | 60.37M | 68.90M | 75.10M | 80.10M | 80.20M |
| Earning assets | - | - | - | - | - |
| Other current assets | 69.17M | 2.10M | 45.70M | - | 232.30M |
| Total liab | 674.01M | 773.80M | 1063.50M | 1079.70M | 787.00M |
| Total stockholder equity | 742.28M | 772.50M | 636.20M | 625.70M | 554.10M |
| Deferred long term liab | - | - | - | - | 30.70M |
| Other current liab | 98.22M | 129.40M | 110.50M | 122.40M | 108.40M |
| Common stock | 14.79M | 14.80M | 14.80M | 14.80M | 14.80M |
| Capital stock | 14.80M | 14.80M | 14.80M | 14.80M | 14.80M |
| Retained earnings | 706.30M | 675.80M | 540.60M | 493.80M | 430.20M |
| Other liab | - | - | - | 49.80M | 47.40M |
| Good will | 28.69M | 30.10M | 81.30M | 83.50M | 77.70M |
| Other assets | - | - | -12.90000M | - | 142.10M |
| Cash | 44.68M | 49.30M | 70.20M | 58.20M | 42.20M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 306.47M | 438.00M | 588.30M | 592.70M | 321.00M |
| Current deferred revenue | - | - | 2.50M | - | - |
| Net debt | 401.92M | 459.90M | 715.30M | 701.00M | 461.00M |
| Short term debt | 99.00M | 201.30M | 368.50M | 322.00M | 84.60M |
| Short long term debt | 86.60M | 188.00M | 356.00M | 309.70M | 74.70M |
| Short long term debt total | 446.60M | 509.20M | 785.50M | 759.20M | 503.20M |
| Other stockholder equity | 55.18M | 81.90M | 55.20M | 117.10M | 109.10M |
| Property plant equipment | - | - | - | 729.50M | 532.90M |
| Total current assets | 579.75M | 513.00M | 579.70M | 654.30M | 504.50M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | - | 426.90M |
| Short term investments | - | - | 61.90M | - | - |
| Net receivables | 224.80M | 203.50M | 200.90M | 210.50M | 212.40M |
| Long term debt | 313.10M | 262.20M | 364.60M | 376.00M | 359.10M |
| Inventory | 241.10M | 258.10M | 262.90M | 331.20M | 230.00M |
| Accounts payable | 109.25M | 105.30M | 104.30M | 148.30M | 128.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -33.98553M | - | 25.60M | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 0.10M | 99.30M | 49.60M | 127.40M | 118.50M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 836.54M | 1033.30M | 1120.00M | 1051.10M | 836.60M |
| Capital lease obligations | 46.90M | 59.00M | 64.90M | 73.50M | 69.40M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -1.90000M | 166.00M | -146.80000M | -199.10000M | 5.50M |
| Change to liabilities | - | - | - | 14.60M | 25.70M |
| Total cashflows from investing activities | -67.33334M | 166.00M | -146.80000M | -199.10000M | -119.40000M |
| Net borrowings | -33.30000M | -296.20000M | 41.20M | 221.80M | 118.90M |
| Total cash from financing activities | -90.09797M | -371.70000M | -5.30000M | 173.90M | 85.90M |
| Change to operating activities | - | - | - | - | -17.90000M |
| Net income | 71.85M | 281.80M | 72.90M | 110.80M | 82.00M |
| Change in cash | 1.23M | -20.90000M | 12.00M | 16.00M | -9.40000M |
| Begin period cash flow | 43.45M | 70.20M | 58.20M | 42.20M | 51.60M |
| End period cash flow | 44.68M | 49.30M | 70.20M | 58.20M | 42.20M |
| Total cash from operating activities | 154.55M | 184.10M | 165.40M | 39.00M | 22.40M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 82.41M | 86.80M | 84.60M | 76.40M | 64.10M |
| Other cashflows from investing activities | - | 251.80M | 4.60M | 14.20M | 4.30M |
| Dividends paid | 35.73M | 41.90M | 33.10M | -33.00000M | -33.00000M |
| Change to inventory | -0.67237M | -5.20000M | 61.50M | -90.40000M | -54.40000M |
| Change to account receivables | -13.63956M | 6.20M | 4.70M | -39.00000M | -33.20000M |
| Sale purchase of stock | -9.60533M | -20.00000M | - | - | - |
| Other cashflows from financing activities | -12.77509M | -13.60000M | -13.40000M | 209.60M | 121.80M |
| Change to netincome | - | - | - | - | -40.20000M |
| Capital expenditures | 65.51M | 84.20M | 149.30M | 235.80M | 148.70M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -21.70804M | 37.90M | 13.60M | -110.10000M | -86.20000M |
| Stock based compensation | 5.20M | 4.70M | 4.10M | 4.80M | 3.50M |
| Other non cash items | 22.00M | -227.10000M | 134.40M | -42.90000M | -11.80000M |
| Free cash flow | 89.04M | 99.90M | 16.10M | -196.80000M | -126.30000M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CSNVY Corbion NV ADR |
1.25 5.62% | 23.50 | 15.33 | 12.66 | 1.07 | 1.43 | 1.19 | 7.66 |
| LIN Linde plc Ordinary Shares |
4.56 0.89% | 516.71 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.61 1.59% | 37.81 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.0013 0.0007% | 190.41 | 30.66 | 24.51 | 4.69 | 4.05 | 4.36 | 15.61 |
| SHW Sherwin-Williams Co |
-3.89 1.21% | 316.90 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.
Piet Heinkade 127, Amsterdam, Netherlands, 1019 GM
| Name | Title | Year Born |
|---|---|---|
| Mr. Olivier Rigaud | Chairman of the Management Board & CEO | 1964 |
| Mr. Eddy Van Rhede van Der Kloot | CFO & Member of Management Board | 1963 |
| Ms. Jacqueline van Lemmen | Chief Operations Officer | 1961 |
| Mr. Marcel Wubbolts | Chief Science & Sustainability Officer | 1963 |
| Jeroen van Harten | Director of Investor Relations | NA |
| Tanno Massar | Director of Corp. Communications | NA |
| Ms. Aurelie Dalbiez | Chief HR Officer | 1977 |
| Mr. Andy Muller | Pres of Sustainable Food Solutions | 1965 |
| Mr. Ruud Peerbooms | Pres of Algae Ingredients | 1969 |
| Mr. Marco Bootz | Pres of Lactic Acid & Specialties | 1972 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.